AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09. November 2023 09:00 ET
|
AVITA Medical
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
19. Oktober 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Announces Preliminary Third Quarter 2023 Financial Highlights and Secures up to $90 million of Non-Dilutive Debt Financing with OrbiMed to Support Growth Initiatives
18. Oktober 2023 09:00 ET
|
AVITA Medical
AVITA Medical announces third quarter 2023 preliminary commercial revenue of $13.5 million and secures up to $90 million of non-dilutive debt financing.
AVITA Medical Receives Best Product Award at the American Association for the Surgery of Trauma
25. September 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Present at the Cantor Global Healthcare Conference
21. September 2023 16:30 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Participate in Upcoming Investor Conferences
06. September 2023 18:45 ET
|
AVITA Medical
VALENCIA, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical to Host Investor Webinar Briefing
14. August 2023 08:00 ET
|
AVITA Medical
VALENCIA, Calif., Aug. 14, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Reports Second Quarter Financial Results
10. August 2023 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of...
AVITA Medical to Announce Second Quarter 2023 Financial Results
20. Juli 2023 16:05 ET
|
AVITA Medical
VALENCIA, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...
AVITA Medical Submits FDA PMA Supplement for RECELL GO
29. Juni 2023 18:21 ET
|
AVITA Medical
VALENCIA, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class...